000 01465 a2200421 4500
005 20250513192622.0
264 0 _c19991013
008 199910s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI7325
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChiaramonte, M G
245 0 0 _aAn IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cSep 1999
300 _a777-85 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a3T3 Cells
650 0 4 _aAnimals
650 0 4 _aCytokines
_xbiosynthesis
650 0 4 _aFemale
650 0 4 _aInterleukin-13
_xantagonists & inhibitors
650 0 4 _aInterleukin-4
_xdeficiency
650 0 4 _aLiver
_xmetabolism
650 0 4 _aLiver Cirrhosis, Experimental
_xprevention & control
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aProcollagen
_xgenetics
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aSchistosomiasis mansoni
_xcomplications
650 0 4 _aTh1 Cells
_ximmunology
650 0 4 _aTh2 Cells
_ximmunology
700 1 _aDonaldson, D D
700 1 _aCheever, A W
700 1 _aWynn, T A
773 0 _tThe Journal of clinical investigation
_gvol. 104
_gno. 6
_gp. 777-85
856 4 0 _uhttps://doi.org/10.1172/JCI7325
_zAvailable from publisher's website
999 _c10448724
_d10448724